78
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers

, , , , &
Pages 2357-2363 | Published online: 02 Nov 2015

References

  • LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
  • ZielinskiJBednarekMKnow the Age of Your Lung Study GroupEarly detection of COPD in a high-risk population using spirometric screeningChest2001119373173611243950
  • DuvallKFrankGWIdentifying chronic obstructive pulmonary disease in primary care of urban underserved patients: tools, applications, and challengesJ Natl Med Assoc2010102757057820690320
  • BalcellsEAntóJMGeaJPAC-COPD Study GroupCharacteristics of patients admitted for the first time for COPD exacerbationRespir Med200910391293130219427776
  • ZielinskiJBednarekMGoŕeckaDIncreasing COPD awarenessEur Respir J200627483385216585092
  • SansoresRHRamírez-VenegasAHernández-ZentenoRMayar-MayaMEPeŕez-BautistaOGVelázquez UncalMPrevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategiesRespir Med2013107458058623313037
  • Montes de OcaMLópez-VarelaMVAcuñaAALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers. Formacioń de Preguntas Clínicas en Formato PICOArch Bronconeumol201551840341625596991
  • BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
  • MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardization of spirometryEur Respir J200526231933816055882
  • Peŕez-PadillaRValdiviaGMuiñoASpirometric reference values in 5 large Latin American cities for subjects aged 40 years or overArch Bronconeumol200642731732516945261
  • RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
  • CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • CasanovaCde TorresJPAguirre-JaímeAThe progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohortAm J Respir Crit Care Med201118491015102121836135
  • Ramírez-VenegasASansoresRHQuintana-CarrilloRHForced expiratory volume in one second decline in patients with chronic obstructive pulmonary disease associated with biomass exposureAm J Respir Crit Care Med20141909996100225172140
  • KohansalRMartínez-CamblorPAgustíABuistASManninoDMSorianoJBThe natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohortAm J Respir Crit Care Med2009180131019342411
  • BlasiFCesanaGContiSThe clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patientsPLoS One201496e10122824971791
  • HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • OharJASadeghnejadAMeyersDADonohueJFBleeckerERDo symptoms predict COPD in smokers?Chest201013761345135320363841
  • FainSBPanthSREvansMDEarly emphysematous changes in asymptomatic smokers: detection with 3 He MR imagingRadiology2006239387588316714465
  • YasunagaKCheŕot-KornobisNEdméJLEmphysema in asymptomatic smokers: quantitative CT evaluation in correlation with pulmonary function testsDiagn Interv Imaging201394660961723601360
  • OfirDLavenezianaPWebbKALamYMO’DonnellDEMechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177662262918006885
  • O’DonnellDELavenezianaPOraJWebbKALamYMOfirDEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPDThorax200964321622319052054
  • TálamoCMontes de OcaMHalbertRPLATINO teamDiagnostic labeling of COPD in five Latin American citiesChest20071311606717218557
  • ElbehairyAFRaghavanNChengSPhysiological characterization of the chronic bronchitis phenotype in GOLD grade 1B COPDChest201514751235124525393126
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 pt 1141814229603117
  • DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
  • CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
  • CelliBDecramerMKestenSLiuDMehraSTashkinDPUPLIFT Study InvestigatorsMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
  • WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
  • US Preventive Services Task ForceScreening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statementAnn Intern Med200814852953418316747
  • TashkinDPLiNKleerupECAcute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPDRespir Res20141510210525175805
  • PriceDFreemanDClelandJKaplanACerasoliFEarlier diagnosis and earlier treatment of COPD in primary carePrim Care Respir J2011201152220871945
  • MiravitllesMSorianoJBGarcía-RíoFPrevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activitiesThorax2009641086386819553233
  • DecramerMMiravitllesMPriceDNew horizons in early stage COPD – improving knowledge, detection and treatmentRespir Med2011105111576158721239156
  • MiravitllesMde la RozaCMoreraJChronic respiratory symptoms, spirometry and knowledge of COPD among general populationRespir Med2006100111973198016626950
  • MiravitllesMde la RozaCNaberanKLambanMGobarttEMartinAUse of spirometry and patterns of prescribing in COPD in primary careRespir Med200710181753176017448651